Get startedLog in
    Picture of PTC Therapeutics logo

    PTCT — PTC Therapeutics Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for PTC Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-252-438-524-559-627
    Depreciation
    Deferred Taxes
    Non-Cash Items91.5158232203252
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital20.436.9-23.8-94.926.3
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-98.6-194-251-357-158
    Capital Expenditures-13.8-17.8-28.2-32-28.4
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-373-544247322-148
    Acquisition of Business
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-387-562219290-177
    Financing Cash Flow Items06110-51.9918
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities61366920.9168646
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash126-79.2-19.198.7314